Rxsight Inc

NASDAQ:RXSTUnited States

RxSight, Inc. is a commercial-stage medical technology company, which is engaged in improving the vision of patients following cataract surgery. The Company’s RxSight Light Adjustable Lens system (RxSight system) is a cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system includes the RxSight Light Adjustable Lens (LAL), the RxSight Light Delivery Device (LDD), and various accessories. Its LAL is an intraocular lens (IOL) made of photosensitive material that changes shape in response to specific patterns of ultraviolet (UV) light generated by its LDD. It designed its RxSight system to address the shortcomings of competitive IOL technologies and provide a solution that doctors can trust to improve visual outcomes. Its RxSight system helps the surgeon perform a standard cataract procedure to implant the LAL and then uses the LDD to modify the lens with the visual correction needed for the patient’s vision outcomes.

Contact Information

Headquarters

100 COLUMBIA STREET, SUITE 120ALISO VIEJO, CA, United States 92656

Phone

949-521-7822

Fax

302-655-5049

Executives

Independent Chairman of the Board

J. Andy Corley

President, Chief Executive Officer, Director

Ron Kurtz

Chief Financial Officer

Shelley Thunen

Chief Operating Officer

Ilya Goldshleger

Chief Commercial Officer

Eric Weinberg